LONN.SW: Lonza Group AG Stock Live Price Graph
Lonza Group AG stock live price (Swiss Franc), charts and analysis. Get LONN.SW stock market news.
Lonza Group AG (LONN.SW)
Loading chart...
About the company
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Company profile
Market News & Analysis
Dividend History
Cash dividends
| Payment | Gross / share | Net / share | Yield | Per 1,000 TRY |
|---|---|---|---|---|
| - | $5 | $5 | 1.05% | - |
| - | $4 | $4 | 0.70% | - |
| - | $4 | $4 | 0.77% | - |
| - | $3.5 | $3.5 | 0.62% | - |
| - | $3 | $3 | 0.58% | - |
What Is LONN.SW? Live LONN.SW Prices and Analysis
LONN.SW, also known as Lonza Group AG, is a leading Swiss multinational company primarily focused on the life sciences sector. Established in 1897, Lonza specializes in the production of pharmaceuticals, biotechnology, and specialty chemicals. Its significance in the global economy is underscored by its critical role in developing and manufacturing products that support health and wellness. Investors closely monitor LONN.SW due to its robust growth prospects, strategic partnerships, and consistent performance in the dynamic life sciences market.
As a prominent player in the healthcare and biological sectors, Lonza has garnered attention from investors seeking exposure to the rapidly evolving biopharmaceutical landscape. The company's dedication to innovation and sustainability positions it well for future growth, making LONN.SW a compelling stock for both long-term investors and traders alike.
Frequently asked questions
What is the LONN.SW stock price?
The latest LONN.SW (Lonza Group AG (LONN.SW)) stock price is 548.8000 CHF. Follow the live quote and chart on this page for real-time updates.
What are LONN.SW's intraday ceiling and floor prices?
For LONN.SW, the intraday ceiling is 552.2000 CHF and the floor is 547.6000 CHF. These levels may update during the session.
What is LONN.SW's previous closing price?
The previous closing price for LONN.SW is 545.6000 CHF.
What is LONN.SW's trading volume?
The current trading volume for LONN.SW is 75,768. Volume can change throughout the session.
Where can I see the live LONN.SW price?
You can follow the live LONN.SW (Lonza Group AG (LONN.SW)) price in the quote area and chart at the top of this Investvio overview page.
Where can I see LONN.SW historical prices and charts?
The current price chart for LONN.SW (Lonza Group AG (LONN.SW)) is on this overview page. For longer historical prices and archive data, open the Archive tab and choose a period to review past performance.